Provided by Tiger Trade Technology Pte. Ltd.

Coherus BioSciences

1.41
-0.0500-3.42%
Post-market: 1.39-0.0200-1.42%19:49 EDT
Volume:605.04K
Turnover:863.05K
Market Cap:217.45M
PE:-1.41
High:1.48
Open:1.45
Low:1.40
Close:1.46
52wk High:2.62
52wk Low:1.09
Shares:154.22M
Float Shares:136.00M
Volume Ratio:0.54
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0011
EPS(LYR):1.43
ROE:-178.39%
ROA:-30.52%
PB:3.57
PE(LYR):0.98

Loading ...

Coherus Oncology Q2 Net Income USD -20.631 Million

Reuters
·
Aug 06

Coherus Oncology Q2 Operating Income USD -32.331 Million

THOMSON REUTERS
·
Aug 06

Coherus Oncology Q2 EPS USD -0.13

THOMSON REUTERS
·
Aug 06

Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 06

Coherus Oncology Inc Expected to Post a Loss of 20 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Coherus, Zumutor collaborate for ZM008, Loqtorzi combination study

TIPRANKS
·
Jun 24

Coherus Enters Trial Collaboration, Supply Agreement With Zumutor Biologics

MT Newswires Live
·
Jun 24

BRIEF-Coherus, Zumutor To Collaborate On ZM008, LOQTORZI Combination Study

Reuters
·
Jun 24

Coherus Oncology, Zumutor Biologics team up on Phase 1 trial combining ZM008 with LOQTORZI

Reuters
·
Jun 24

Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate Zm008 in Combination With Loqtorzi® (Toripalimab-Tpzi)

THOMSON REUTERS
·
Jun 24

Coherus Oncology: Co to Supply Loqtorzi; Zumutor to Sponsor Phase 1 Trial; Both Retain Commercial Rights

THOMSON REUTERS
·
Jun 24

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Coherus Biosciences (CHRS)

TIPRANKS
·
Jun 22

Coherus Oncology dismisses EY, names PwC as new auditor

Reuters
·
Jun 16

Sona Nanotech appoints ex-Coherus executive Michael Fleming to board

Reuters
·
Jun 11

Coherus Oncology shareholders approve stock option repricing plan at annual meeting

Reuters
·
Jun 01

Analysts’ Top Healthcare Picks: Coherus Biosciences (CHRS), Medicinova (MNOV)

TIPRANKS
·
May 29

Coherus Oncology (CHRS) Q1 Loss Of US$36.9 Million Tests Bullish Growth Narratives

Simply Wall St.
·
May 13

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Coherus Biosciences (CHRS), Moderna (MRNA) and Skye Bioscience (SKYE)

TIPRANKS
·
May 12

Coherus Oncology Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Coherus Oncology Q1 Sales USD 12.31 Million Vs. IBES Estimate USD 14.3 Million

Reuters
·
May 12